Eber Guzman-Cruz, B.S.
- Center for Cancer Research
- National Cancer Institute
Postbaccalaureate Fellow
RESEARCH SUMMARY
Eber received his Bachelor of Science in Molecular Biology from Towson University in 2024, where he conducted research on the development of antibody-based therapeutics to combat factor VIII resistance in individuals affected by Hemophilia A. He currently serves as a Postbaccalaureate Fellow in Dr. Mitchell Ho’s lab at the National Cancer Institute, where he is working on the development of a CD3+ bispecific antibody targeting mesothelin-expressing cancers. In 2025, Eber received the Outstanding Oral Presentation Award at the NCI Annual CCR Colloquium.
Areas of Expertise
Antibody Engineering
T Cell Engagers
Cancer Therapy